Treatment options for COVID-19: scoping review of clinical studies (search done on 20 April 2020)
Citation: Shaikh K, Shrestha C, Dutta D. Treatment options in people with COVID19: Selecting the best armamentarium against the novel virus. JPMA: The Journal of the Pakistan Medical Association. 2020 May 1;70(5):S69-73.
What is this? Many options have been suggested as possible treatments for COVID-19.
In this rapid scoping review, the authors searched for clinical studies evaluating treatments for patients with COVID-19. They did not restrict their search by language of publication. They did the search for articles published up to March 2020 on 20 April 2020. They identified reports for nearly 300 clinical studies and noted the existence of more than 350 ongoing randomized trials.
What was found: At the time of this review, the included studies did not provide evidence that was good enough to recommend any specific treatment regimen for COVID-19 patients.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.